Naji Gehchan - 22 Jan 2025 Form 3 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Signature
By: /s/ Samantha Eldredge, as Attorney-in-Fact
Issuer symbol
KYTX
Transactions as of
22 Jan 2025
Net transactions value
$0
Form type
3
Filing time
24 Jan 2025, 20:00:05 UTC

No securities are beneficially owned.

Remarks:

Chief Medical & Development Officer; Exhibit 24 - Power of Attorney